SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-22-030743
Filing Date
2022-06-01
Accepted
2022-06-01 17:20:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea161026-424b5_inmedpharma.htm 424B5 3911
2 GRAPHIC image_001.jpg GRAPHIC 23363
  Complete submission text file 0001213900-22-030743.txt   37197
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-262532 | Film No.: 22988359
SIC: 2834 Pharmaceutical Preparations